About us

MISSION
To drive global projects that integrate medicine, science, technology, and strategy, connecting international talent with robust management structures to transform high-value ideas into real, sustainable, and impactful solutions.FADIPAR as a platform that combines operational excellence, strategic vision, and academic rigor, creating collaborative ecosystems capable of raising the standards of innovation on a global scale.
VISION
To be a leading international holding company in medical-scientific innovation and strategic management, recognized for its ability to lead complex initiatives, accelerate talent development, drive emerging technologies, and build projects that transform health, science, and education in multiple regions around the world.We aspire to establish ourselves as a global connector that brings together institutions, professionals, and organizations to create solutions that define the future.
HISTORY

FADIPAR Projects S.L. was founded to bridge medical and scientific knowledge with technological innovation and strategic project management. Its model combines academic excellence, applied innovation, and multi-level management, enabling it to participate in highly demanding medical, surgical, and technological initiatives. FADIPAR growth FADIPAR underpinned by partnerships with institutions, universities, research centers, and companies in Europe and Latin America, acting as a bridge between talent, organizations, and opportunities. Today, it operates as a specialized holding company that promotes advanced training programs, develops scientific solutions, manages complex clinical and educational projects, and represents initiatives that require rigor, innovation, and strategic vision. With a solid identity and a forward-looking approach, FADIPAR specialized knowledge into projects with a real impact on medicine, technology, and society.

logo without background

Experts in development, scientific direction, and management of medical-surgical projects.

photo 2025 11 20 09 06 54

Afranio Luis Restrepo Villarroel, MBA, MSc, is a business administrator with extensive experience in strategic management and project development. As Executive Director of FADIPAR Projects S.L., he oversees the planning, operation, and comprehensive coordination of the company’s programs and business units.

img 6611

Dr. Juan Carlos Sánchez España, MD PhD Lic. No. 53021 – COMB), is an ophthalmic surgeon specializing in oculoplastic surgery. As Scientific Director of FADIPAR Projects S.L., he oversees the academic, scientific, and surgical aspects of all projects.

Medical Responsibility and Scientific Supervision

FADIPAR Projects S.L. guarantees that all health-related content published on this website is reviewed, validated, and supervised by a licensed medical professional, who is responsible for ensuring its accuracy, up-to-date status, and scientific consistency.

Medical Content Director: Dr. Juan Carlos Sánchez España, MD, PhD. Specialist in Ophthalmology and Oculoplastic Surgery. COMB Member COMB 53021. Responsible for the medical review and validation of the health-related content on this website.

Editorial Quality Control

FADIPAR a continuous quality control system for the development and review of medical content, based on:

• Pre-publication verification

• Specialized medical supervision

• Periodic editorial review (at least once a year)

• Updating or removing outdated content

• Guarantee of independence from commercial interests

• Use of scientific sources and recognized clinical standards

Top view of a diverse team collaborating in an office setting with laptops and tablets, promoting cooperation.
Our Work Team
86335eb5 d924 4aae bc68 e1bd75a47ccb

Notice of complementary information

The information provided on this website is for informational and educational purposes only. It does not replace, but rather complements, the relationship between the healthcare professional and the patient or visitor. If you have any questions regarding your health, you should consult your healthcare professional.